Skip to main content
. 2020 Nov 13;10(4):229. doi: 10.3390/jpm10040229

Figure 3.

Figure 3

PCA score plots showing the clustering of cancer pre-RT samples A, cancer post-RT samples B, and control samples C. Shown are two the first components responsible for 23.1% of the variability of the serum samples (panel A) and 43.5% of the variability for the exosome samples (panel B).